|
|
| | RGFP 109 Basic information |
| Product Name: | RGFP 109 | | Synonyms: | RGFP 109 N-[6-(2-Aminophenylamino)-6-oxohexyl]-4-methylbenzamide;RG 2833;RG2833;RG-2833;RGFP 109;RGFP109;RGFP-109;RG2833(RGFP109) | | CAS: | 1215493-56-3 | | MF: | C20H25N3O2 | | MW: | 339.43 | | EINECS: | | | Product Categories: | Inhibitors | | Mol File: | 1215493-56-3.mol |  |
| | RGFP 109 Chemical Properties |
| Boiling point | 620.1±50.0 °C(Predicted) | | density | 1.163±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | insoluble in H2O; ≥16.95 mg/mL in DMSO; ≥8.05 mg/mL in EtOH with gentle warming and ultrasonic | | form | Powder | | pka | 14.62±0.70(Predicted) |
| | RGFP 109 Usage And Synthesis |
| Uses | RGFP 109 is a histone deacetylase (HDAC) inhibitor that has shown to reverse FXN gene silencing in short-term studies of Friedreich ataxia (FRDA) patient cells. | | target | HDAC1 |
| | RGFP 109 Preparation Products And Raw materials |
|